FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/08/009210 [Registered on: 01/08/2017] Trial Registered Prospectively
Last Modified On: 06/07/2019
Post Graduate Thesis  No 
Type of Trial  BA/BE 
Type of Study    
Study Design  Randomized, Crossover Trial 
Public Title of Study   Clinical study of SPIL1506 and reference1506 in subjects with indication of Bilateral Cataract Surgery 
Scientific Title of Study   A Multi-Centeric, Open-Label, Randomized, Cross-over, Aqueous Humor Bioequivalence Study of Loteprednol Etabonate Ophthalmic Suspension 0.5% (Sun Pharmaceutical Industries, Ltd.) and Lotemax® (Loteprednol Etabonate Ophthalmic Suspension 0.5%; Bausch & Lamb, Inc.) in Subjects With Indicated Bilateral Cataract Surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
CLR_15_06 Version 01 Amendment 00 dated 16 Nov 2015  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Dr Mudgal Kothekar MD 
Designation  Associate Vice President - Clinical Development 
Affiliation  Sun Pharma Advanced Research Company Limited 
Address  Sun Pharma Advanced Research Company Ltd, 17/B,Mahal Industrial Estate,Mahakali Caves Road,Andheri (E),Mumbai

Mumbai
MAHARASHTRA
400093
India 
Phone  912266455645  
Fax  912266455685  
Email  clinical.trials@sparcmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr Mudgal Kothekar MD 
Designation  Associate Vice President - Clinical Development 
Affiliation  Sun Pharma Advanced Research Company Limited 
Address  Sun Pharma Advanced Research Company Ltd, 17/B,Mahal Industrial Estate,Mahakali Caves Road,Andheri (E),Mumbai

Mumbai
MAHARASHTRA
400093
India 
Phone  912266455645  
Fax  912266455685  
Email  clinical.trials@sparcmail.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Dr Mudgal Kothekar MD 
Designation  Associate Vice President - Clinical Development 
Affiliation  Sun Pharma Advanced Research Company Limited 
Address  Sun Pharma Advanced Research Company Ltd, 17/B,Mahal Industrial Estate,Mahakali Caves Road,Andheri (E),Mumbai

Mumbai
MAHARASHTRA
400093
India 
Phone  912266455645  
Fax  912266455685  
Email  clinical.trials@sparcmail.com  
 
Source of Monetary or Material Support  
Sun Pharmaceutical Industries Ltd,F.P No. 27, Part Survey No. 27, C.S No.1050,Opposite Pratham Enclave, Tandalja,  
 
Primary Sponsor  
Name  Sun Pharmaceutical Industries Ltd 
Address  F.P No. 27, Part Survey No. 27, C.S No.1050,Opposite Pratham Enclave, Tandalja, Vadodara, Gujarat 390020 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 17  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sujata Navare  Aster Aadhar Hospital (Prerana Hospital Ltd.)  Room No. 211, Ophthalmology Department, Aster Aadhar Hospital, R.S. No.628, B Ward, Near Shastri Nagar KMT Workshop, Kolhapur - 416012
Kolhapur
MAHARASHTRA 
9225068511

sujatanavare.aacr@gmail.com 
Dr Suraj Bhagde  Bhaktivedanta Hospital & Research Institute   Srishti Complex, Sector 1, Bhaktivedanta Swami Marg, Mira Road East, Thane, Maharashtra 401107, India.
Mumbai
MAHARASHTRA 
9833547425

drsuraj.b@bhaktivedantahospital.com 
Dr Prashanth C N  Dr. B. R. Ambedkar Medical College   Room No. 03, 2nd Floor, Ophthalmology Department, New OPD building, Dr.B.R. Ambedkar Medical College and Hospital, Shampura Main Road, K.G.Halli, Bangalore-560045
Bangalore
KARNATAKA 
9880708204

prashanthcndoctor@gmail.com 
Dr Shalini Mohan  G.S.V.M Medical College  Department of Opthalmology,Ward no : 08 LLR Hospital, Swaroop Nagar, Kanpur-208005 (U.P.)
Kanpur Nagar
UTTAR PRADESH 
9506740966

drshalinimohan.research@gmail.com 
Dr Hemaxi Desai  GCS Medical College, Hospital & Research Centre  Department of ophthalmology, Opp. DRM Office, Nr. Chamunda Bridge, Naroda Road, Ahmedabad - 380 025, Gujarat, India
Ahmadabad
GUJARAT 
9898065645

hemaxi.patel@gcsmc.org 
Dr Rekha Mudhol  KLES Dr. Prabhakar Kore Hospital and Medical Research Centre  SMO office, Second Floor, Near psycharty ward, Nehru Nagar, Belagavi.590010
Belgaum
KARNATAKA 
9449938997

rekhamudhol@gmail.com 
Dr Smita Sapate  Mahatme Eye Bank & Eye Hospital  2163/C Chintaman Nagar, Somalwada, Nagpur-440015, Maharashtra , India.
Nagpur
MAHARASHTRA 
09922924637

drsmitaPsapate@gmail.com 
Dr Abhijeet Deshpande  Meditrina Institute of Medical Sciences   278,Central Bazar Road,Ramdaspeth,NAGPUR - 440 012, Maharashtra , India.
Nagpur
MAHARASHTRA 
9422105512

abhidesh123@reddifmail.com 
Dr S Gopinath  Mysore Medical College and Research Institute and Associated Hospitals  Irwin Road, Mysore, Karnataka 570021, India.
Mysore
KARNATAKA 
9448101419

gsgopinath61@gmail.com 
Dr Rupal Shah  New Vision Laser Center Pvt. Ltd.   101, Tower A,Atlantis K-10, First Floor, Atlantis, Sarabhai Compound, Opp Honest Restaurant, Near Genda Circle, Vikram Sarabhai Road, Vadodara 390007, Gujarat, India.
Vadodara
GUJARAT 
9376271000

rupal@newvisionindia.com 
Dr Rekha Khandelwal  NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital   Dept of Opthalmology, Digdoh Hills,Hingna, Nagpur, 440019, Maharashtra
Nagpur
MAHARASHTRA 
9823515550

anand.rathi07@gmail.com 
Dr Kalyani VKS  PBMAs H. V. Desai Eye Hospital   Room No 202., Second Floor, Dharmacy Nesay Superspecality Building, S.No 93, Tarawade Vasri, Mohammadwadi Road, Hadapsar, Pune 411060
Pune
MAHARASHTRA 
9423001834

drkalyanimark@yahoo.co.in 
Dr R R Sudhir  Sankara Nethralaya, Medical & Vision Research Foundation  New No.41 ( Old No.18),C.U.Shah Cornea Services A SIVASAILAM BLOCK No. 21, Pycrofts Garden Road (off. Haddows Road, Nungambakkam, Chennai 600 006. Tamil Nadu, India
Chennai
TAMIL NADU 
9444174847

rrsudhir@Yahoo.com 
Dr Ashwini  Sapthagiri Institute of Medical Sciences and Research Centre  Room no:02, First floor, Ophthalmology dept , No. 15, Chikkasandara, Hessarghatta main Road, Bangalore-560090
Bangalore
KARNATAKA 
9731799114

ashwini_kulenur@yahoo.com 
Dr Sheela Kerkar  Seth G. S. Medical College & KEM Hospital  OPD No.36,Department of Ophthalmology, Seth G.S. Medical College & KEM Hospital, Old Building, Ground Floor, Acharya Donde Marg, Parel, Mumbai. – 400012.
Mumbai
MAHARASHTRA 
9820297576

mshah@parshwalifescieces.in 
Dr Anupama Vyas  Shalby Hospitals   9th Floor, Clinical research department, Shalby Hospitals, Opposite Karnavati Club, S.G.Highway, Ahmedabad – 380015, Gujarat, India.
Ahmadabad
GUJARAT 
9714821300

anupama.vyas@shalby.org 
Dr Tinku Bali Razdan  Sir Ganga Ram Hospital  Rajinder Nagar, New Delhi -110060, India.
New Delhi
DELHI 
9999901122

tinkubali2020@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 15  
Name of Committee  Approval Status 
EC-Aster-Aadhar-DrSujata  Approved 
EC-GSMC  Approved 
EC-GSVM-DrShalini  Approved 
EC-KLE University  Approved 
EC-Shalby Hospitals  Approved 
EC-Sir Gangaram Hospital  Approved 
EC-Vision Research Foundation  Approved 
ECCKS  Approved 
IEC-Dr-Ambedkar-medical-college  Approved 
IEC-Mahatma Eye Bank and Eye Hospital  Approved 
IEC-Mysore Medical College  Approved 
IEC-NKP Salve Institute of Medical sciences  Approved 
IEC-PBMA’s H. V. Desai Eye Hospital_Pune  Approved 
IEC-Sapthagiri Institute  Approved 
Medtrinia IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z984||Cataract extraction status, eligible to undergo bilateral cataract extraction ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Reference1506 Ophthalmic suspension  Reference product1506 manufactured by Bausch & Lomb, Inc.It is 0.5% ophthalmic suspension of loteprednol etabonate 
Intervention  SPIL1506 Ophthalmic suspension  SPIL1506 manufactured by Sun Pharmaceutical Industries Limited,India 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1.Willing and able to provide written informed consent prior to any study procedures being performed.
2. Ready and able to follow all instructions and attend all study visits.
3.Have planned bilateral cataract extraction
4. Agree to perform pregnancy test before participation in the trial
5.Agree to use an acceptable method of contraception for the duration of the study or not be of childbearing potential.
 
 
ExclusionCriteria 
Details  1.Have any active ocular disease in either eye that requires prescription treatment
2.Have an active infection (bacterial, viral or fungal) of either eye or eyelids
3.Pregnant, nursing, or planning a pregnancy; or be a woman that has a positive pregnancy test.
4.use of an investigational drug or device within 30 days of Visit 1.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment    
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Pharmacokinetic parameter :(AUC0-6) and Cmax   1.Pharmacokinetic parameter : over a period of approximately 7 to 63 days
 
 
Secondary Outcome  
Outcome  TimePoints 
None  Not Applicable 
 
Target Sample Size   Total Sample Size="418"
Sample Size from India="418" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is open label Bioequivalence study. 
Close